XML 67 R48.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Issued share capital, share premium account and share options (Tables)
12 Months Ended
Mar. 31, 2024
Issued share capital, share premium account and share options  
Schedule of share capital

​

​

​

​

​

​

​

​

​

​

​

​

​

​

At March 31, 

​

​

​

    

2024

    

2023

    

2022

​

​

​

 

€M

 

€M

 

€M

Authorized/Share Capital reorganization

​

​

​

​

​

​

​

​

1,550,000,000 ordinary equity shares of 0.600 euro cent each

​

​

 

9.3

 

9.3

 

9.3

1,368,000,000 'B' Shares of 0.050 euro cent each

​

​

 

0.7

 

0.7

 

0.7

1,368,000,000 Deferred shares of 0.050 euro cent each

​

​

 

0.7

 

0.7

 

0.7

​

​

​

 

10.7

 

10.7

​

10.7

Allotted, called-up and partly paid:

​

​

​

​

​

​

​

​

1,134,528,528 ordinary equity shares of 0.600 euro cent each

​

​

 

—

 

—

 

6.8

1,138,674,528 ordinary equity shares of 0.600 euro cent each

​

​

 

—

 

6.9

 

—

1,140,045,528 ordinary equity shares of 0.600 euro cent each

​

​

​

6.9

​

—

​

—

Schedule of share premium account

​

​

​

​

​

​

​

​

​

​

​

​

​

​

At March 31, 

​

    

​

​

2024

    

2023

    

2022

​

 

​

​

€M

 

€M

 

€M

Balance at beginning of year

 

​

​

1,379.9

 

1,328.2

 

1,161.6

Net proceeds from shares issued

​

​

​

16.4

​

31.7

​

46.8

Share premium receivable on shares issued

​

​

​

8.0

​

20.0

​

119.8

Balance at end of year

 

​

​

1,404.3

 

1,379.9

 

1,328.2

Schedule of share options outstanding

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

Share

​

Weighted Avg.

​

    

​

​

​

​

Options

    

Exercise

​

     

​

​

​

​

M

     

Price (€)

Outstanding at March 31, 2021

 

​

​

​

​

30.0

​

9.83

Granted

 

​

​

​

​

—

​

—

Forfeited

 

​

​

​

​

(0.7)

​

12.98

Exercised

​

​

​

​

​

(6.5)

​

7.23

Outstanding at March 31, 2022

 

​

​

​

​

22.8

​

10.57

Granted

 

​

​

​

​

—

​

—

Forfeited

​

​

​

​

​

—

​

—

Exercised

 

​

​

​

​

(4.1)

​

7.64

Outstanding at March 31, 2023

 

​

​

​

​

18.7

​

11.24

Granted

​

​

​

​

​

—

​

—

Forfeited

​

​

​

​

​

(0.7)

​

11.12

Exercised

​

​

​

​

​

(1.4)

​

12.00

Outstanding at March 31, 2024

 

​

​

​

​

16.6

​

11.18

Schedule of range of exercise prices and weighted average remaining contractual life

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

​

No.

​

Remaining

​

​

​

​

Exercise

​

options

​

contractual

​

​

​

​

price

​

outstanding

​

life

​

​

​

​

€

​

M

     

(years)

Unvested

​

​

​

11.12

​

16.0

​

4.9

Vested

​

​

​

11.12

​

0.5

​

1.9

Vested

​

​

​

12.00

​

0.1

​

0.4

Weighted average

​

​

​

11.18

​

16.6

​

4.7